Dylana Loobeek, Lenka Pacnerová, Jos Twisk, Cynthia So-Osman
{"title":"如何分析红细胞输注对贫血患者临床预后的影响?从术前贫血中分离红细胞输注对术后预后的影响。","authors":"Dylana Loobeek, Lenka Pacnerová, Jos Twisk, Cynthia So-Osman","doi":"10.1111/trf.18224","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Preoperative anemia is associated with worse clinical postoperative outcomes and a higher risk of receiving red blood cell (RBC) transfusions. It is challenging to disentangle the effect of preoperative anemia from the effect of receiving RBC transfusions on postoperative clinical outcomes such as length of hospital stay (LOS). When analyzing the association of preoperative anemia on LOS, it is important to be able to analyze RBC transfusions as a mediator in this relationship. In this paper, the background and application of mediation analysis is outlined as a statistical methodology in transfusion medicine research.</p><p><strong>Study design and methods: </strong>To explain the methodology of mediation analysis, a database from a previously reported clinical study was used (So-Osman C. et al. 2014) with anemia as the exposure variable and LOS as the primary outcome. Both the product-of-coefficients method and the change-in-coefficients method are used for mediation analysis, and linear regression models were used.</p><p><strong>Results: </strong>In the example of a simplified analysis, two-thirds of the effect could be attributed to mediation. This result was obtained by both the product-of-coefficients method and the change-in-coefficients method.</p><p><strong>Discussion: </strong>Mediation is assessed in a similar way as confounding, but the interpretation of the results is totally different. It is, therefore, of critical importance to distinguish between potential mediators and potential confounders in transfusion research. Since the calculation reported in the results is merely used as an example to show the methodology, e.g. ignoring confounding, the result should not be interpreted as scientific research data.</p>","PeriodicalId":23266,"journal":{"name":"Transfusion","volume":" ","pages":""},"PeriodicalIF":2.5000,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"How do I analyze the role of red blood cell transfusions on clinical outcome in anemic patients? Disentangling the effect of red blood cell transfusions from pre-operative anemia on post-operative outcome.\",\"authors\":\"Dylana Loobeek, Lenka Pacnerová, Jos Twisk, Cynthia So-Osman\",\"doi\":\"10.1111/trf.18224\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Preoperative anemia is associated with worse clinical postoperative outcomes and a higher risk of receiving red blood cell (RBC) transfusions. It is challenging to disentangle the effect of preoperative anemia from the effect of receiving RBC transfusions on postoperative clinical outcomes such as length of hospital stay (LOS). When analyzing the association of preoperative anemia on LOS, it is important to be able to analyze RBC transfusions as a mediator in this relationship. In this paper, the background and application of mediation analysis is outlined as a statistical methodology in transfusion medicine research.</p><p><strong>Study design and methods: </strong>To explain the methodology of mediation analysis, a database from a previously reported clinical study was used (So-Osman C. et al. 2014) with anemia as the exposure variable and LOS as the primary outcome. Both the product-of-coefficients method and the change-in-coefficients method are used for mediation analysis, and linear regression models were used.</p><p><strong>Results: </strong>In the example of a simplified analysis, two-thirds of the effect could be attributed to mediation. This result was obtained by both the product-of-coefficients method and the change-in-coefficients method.</p><p><strong>Discussion: </strong>Mediation is assessed in a similar way as confounding, but the interpretation of the results is totally different. It is, therefore, of critical importance to distinguish between potential mediators and potential confounders in transfusion research. Since the calculation reported in the results is merely used as an example to show the methodology, e.g. ignoring confounding, the result should not be interpreted as scientific research data.</p>\",\"PeriodicalId\":23266,\"journal\":{\"name\":\"Transfusion\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-04-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Transfusion\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/trf.18224\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/trf.18224","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:术前贫血与较差的临床术后预后和接受红细胞(RBC)输血的高风险相关。将术前贫血的影响与接受红细胞输血对术后临床结果(如住院时间(LOS))的影响区分开来是具有挑战性的。在分析术前贫血与LOS的关系时,重要的是能够分析红细胞输血在这种关系中的中介作用。本文概述了中介分析作为一种统计方法在输血医学研究中的背景和应用。研究设计和方法:为了解释中介分析的方法,使用了先前报道的临床研究的数据库(So-Osman C. et al. 2014),以贫血为暴露变量,LOS为主要结局。采用系数乘积法和系数变化法进行中介分析,并采用线性回归模型。结果:在一个简化分析的例子中,三分之二的效果可以归因于中介。采用系数乘积法和系数变化法均可得到上述结果。讨论:调解的评估方式与混淆类似,但对结果的解释却完全不同。因此,在输血研究中区分潜在的介质和潜在的混杂因素至关重要。由于结果中报告的计算仅作为示例来展示方法,例如忽略混淆,因此不应将结果解释为科学研究数据。
How do I analyze the role of red blood cell transfusions on clinical outcome in anemic patients? Disentangling the effect of red blood cell transfusions from pre-operative anemia on post-operative outcome.
Background: Preoperative anemia is associated with worse clinical postoperative outcomes and a higher risk of receiving red blood cell (RBC) transfusions. It is challenging to disentangle the effect of preoperative anemia from the effect of receiving RBC transfusions on postoperative clinical outcomes such as length of hospital stay (LOS). When analyzing the association of preoperative anemia on LOS, it is important to be able to analyze RBC transfusions as a mediator in this relationship. In this paper, the background and application of mediation analysis is outlined as a statistical methodology in transfusion medicine research.
Study design and methods: To explain the methodology of mediation analysis, a database from a previously reported clinical study was used (So-Osman C. et al. 2014) with anemia as the exposure variable and LOS as the primary outcome. Both the product-of-coefficients method and the change-in-coefficients method are used for mediation analysis, and linear regression models were used.
Results: In the example of a simplified analysis, two-thirds of the effect could be attributed to mediation. This result was obtained by both the product-of-coefficients method and the change-in-coefficients method.
Discussion: Mediation is assessed in a similar way as confounding, but the interpretation of the results is totally different. It is, therefore, of critical importance to distinguish between potential mediators and potential confounders in transfusion research. Since the calculation reported in the results is merely used as an example to show the methodology, e.g. ignoring confounding, the result should not be interpreted as scientific research data.
期刊介绍:
TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.